Cor Vasa 2021, 63(6):646-650 | DOI: 10.33678/cor.2021.022

Coronary ostial assessment of myeloperoxidase level correlated to severity of coronary artery disease

Noha Hassanin Hanbolya, Yasser Kamel Gaber Baghdadya, Mohammed Helmy Aly Ahmedb, Assem Abdelaziz Hashada
a Cardiovascular Department, Faculty of Medicine, Cairo University, Cairo, Egypt
b Faculty of Medicine, Cairo University, Cairo, Egypt

Background: Myeloperoxidase participates in proatherogenic biological activities related to the evolution of cardiovascular disease including initiation, propagation, and acute complications of atherosclerotic process. Aim of study: We aimed to identify the relationship between myeloperoxidase (MPO) level at the ostium of coronary arteries and severity of coronary artery disease (CAD) .

Methods: Our study population was divided into two groups: group A and B. Group A included 43 patients with non-ST elevation myocardial infarction (NSTEMI) who underwent coronary angiography. Group B included 43 subjects free from CAD as proved by stress ECG or stress thallium study. MPO level was assessed by coronary osteal sampling of CAD group and peripheral venous sampling of both groups. The severity of CAD was studied using the Gensini & CASS scores.

Results: There was a significant difference in MPO level between both groups (p = 0.002) . Serum MPO was correlated to coronary artery disease as evaluated using Gensini score (p = 0.002) & CASS score (p = 0.05). Peripheral venous sample of MPO correlated with coronary osteal samples in CAD group.

Conclusions: Serum MPO was correlated to severity of coronary artery disease. The peripheral venous level of MPO reflected the osteal coronary levels of MPO. Coronary ostium is a simple, accessible and reliable site for coronary sampling.

Keywords: Acute coronary syndrome, Coronary blood sampling, Gensisi score, Myeloperoxidase

Received: December 8, 2020; Revised: December 8, 2020; Accepted: February 7, 2021; Published: December 13, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hanboly NH, Baghdady YKG, Aly Ahmed MH, Hashad AA. Coronary ostial assessment of myeloperoxidase level correlated to severity of coronary artery disease. Cor Vasa. 2021;63(6):646-650. doi: 10.33678/cor.2021.022.
Download citation

References

  1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126. Go to original source... Go to PubMed...
  2. Takahiko N, Makiko U, Kazuo H, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894-2900. Go to original source... Go to PubMed...
  3. Khine HW, Teiber JF, Haley RW, et al. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study. J Atherosclerosis 2017;36:156-162. Go to original source... Go to PubMed...
  4. Lemin Z, Benedicta N, Marie-Luise B, et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disea. J Clin Invest 2004;114:529-541. Go to original source...
  5. Vita J, Brennan M, Gokce N, et al.Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004;110:1134-1139. Go to original source... Go to PubMed...
  6. Seekamp A, Ward PA. Ischemia-reperfusion injury. Agents Actions Suppl 1993;41:137-152.
  7. Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes. Mediators Inflamm 2008;2008:135625. Go to original source... Go to PubMed...
  8. Stephen J, Stanley L. Myeloperoxidase and Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2005;25:1102-1111. Go to original source... Go to PubMed...
  9. Wilson T, Yuping W, Stephen J, Stanley L. Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery Disease. Clin Chem 2011;57:33-39. Go to original source... Go to PubMed...
  10. Martins C, Mara C, Henrique A, et al. Myeloperoxidase Content is a Marker of Systemic Inflammation in a Chronic Condition: The Example Given by the Periodontal Disease in Rats. Mediators Inflamm 2009;2009:760837. Go to original source... Go to PubMed...
  11. Jaumdally R, Varma C, Macfadyen RJ, et al. Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? Eur Heart J 2007;28:929-940. Go to original source... Go to PubMed...
  12. Crittenden MD. Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites. Ann Thorac Surg 2001;72:S2220-S2226. Go to original source... Go to PubMed...
  13. Kabbani S, Watkins M, Holoch P, et al. Platelet reactivity in coronary ostial blood: a reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy. J Thromb Thrombolysis 2001;12:171-176. Go to original source... Go to PubMed...
  14. Ringqvist I, Fisher L, Mock M, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 1983;71:1854-1866. Go to original source... Go to PubMed...
  15. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. Go to original source... Go to PubMed...
  16. Amir F, Laleh G, Sahar R, Ehsan M. Positive Correlation between Microalbuminuria and Severity of Coronary Artery Stenosis in Patients with Type 2 Diabetes Mellitus. Acta Medica Iranica 2013;51:231-235. Go to PubMed...
  17. Baseri M, Heidari R, Mahaki B, et al. Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina. Adv Biomed Res 2014;3:139. Go to original source... Go to PubMed...
  18. Ndrepepa G, Braun S, Mehilli J, et al. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 2008;38:90-96. Go to original source... Go to PubMed...
  19. Mocatta T, Pilbrow A, Cameron V, et al. Plasma levels of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007;49:1993-2000. Go to original source... Go to PubMed...
  20. Düzgünçinar Ö, Yavuz B, Hazirolan T, et al. Plasma myeloperoxidase is related to the severity of coronary artery disease. Acta Cardiologica 2008;63:147-152. Go to original source... Go to PubMed...
  21. Zhang R., Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001;286:2136-2142. Go to original source... Go to PubMed...
  22. Cavusoglu E, Chopra V, Gupta A, et al. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography. Am J Cardiol 2006;98:1189-1193. Go to original source... Go to PubMed...
  23. de Azevedo Lucio E, Gonçalves S, Ribeiro J, et al. Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome. Inflamm Res 2011;60:137-142. Go to original source... Go to PubMed...
  24. Kubala L, Lu G, Baldus S, et al. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta 2008;394:59-62. Go to original source... Go to PubMed...
  25. Fong SW, Few LL, See Too WC, et al. Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease. BMC Res Notes 2015;8:679. Go to original source... Go to PubMed...
  26. Kirbiš S, Breskvar UD, Šabovič M, et al. Inflammation markers in patients with coronary artery disease-comparison of intracoronary and systemic levels. Wien Klin Wochenschr 2010;122:31-34. Go to original source... Go to PubMed...
  27. Aggarwal A, Schneider DJ, Terrien EF, et al. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. Am J Cardiol 2004;93:6-9. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.